News
Health Matters: Health Canada approves Ozempic to help reduce kidney decline
Health Canada has approved Ozempic in an effort to help reduce the risk of kidney decline for patients living with Type 2 diabetes. The decision comes after an international clinical trial found the risk of deteriorating kidney function was 24 per cent lower in patients taking Ozempic compared to those taking a placebo injection.
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as January.
Canada has approved Novo Nordisk's diabetes drug, Ozempic, to cut chronic kidney disease progression and reduce the risk of ...
With shortages of Ozempic at U.S. pharmacies, some Americans have been turning to Canada and Mexico to buy the medication, a Type 2 diabetes treatment many people are using off-label to lose ...
Ozempic may be adding some spring to your step — but it might also be taking a bite out of your smile. As the popularity of weight-loss drugs surges, a new concern is emerging: “Ozempic teeth.” ...
Novo Nordisk said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback